1. Brainware University Digital Repository
  2. Serial Abstracting Service
  3. Journal & Magazine Article Abstracts
  4. Indian Journal of Pharmacology
  5. Vol 58, No. 3, 2026
Please use this identifier to cite or link to this item: http://111.93.178.142:25000/jspui/handle/123456789/4937
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAastha Khanna-
dc.date.accessioned2026-05-29T12:14:04Z-
dc.date.available2026-05-29T12:14:04Z-
dc.date.issued2026-05-29-
dc.identifier.urihttp://111.93.178.142:25000/jspui/handle/123456789/4937-
dc.descriptionVol 58, No. 3, p 166en_US
dc.language.isoenen_US
dc.subjectGlucsgon-like peptide-1 antagonisten_US
dc.subjectobesityen_US
dc.subjectsemaglutideen_US
dc.subjectsemaglutide treatment effect in pepole with boesity trialsen_US
dc.subjecttype 2 diabetesen_US
dc.titleSemaglutide in obesity and type 2 diabetes : A review of clinical trial evidence from 1 to 5 semaglutide treatment effect in people with obesity programen_US
dc.typeOtheren_US
Appears in Collections:Vol 58, No. 3, 2026

Files in This Item:
File Description SizeFormat 
1.pdfVol 58, No. 3, p 166150.53 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.